Vermillion Wealth Management, Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1737012
ROSEMOUNT, MN
Position in NBIX
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$922
New position
Shares Held
7
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Vermillion Wealth Management, Inc. holds $22,804 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
308 | $9,276 | |
| 2 | VTRS |
Viatris Inc
|
261 | $3,526 | |
| 3 | RMTI |
Rockwell Medical, Inc.
|
360 | $3,204 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
3 | $1,778 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
43 | $1,028 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
7 | $922 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
128 | $828 | |
| 8 | ZTS |
Zoetis Inc.
|
6 | $709 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $922 | 7 | Shares | Sole | 2026-04-17 | |
| No filing history on record for this holder in this stock. | ||||||